Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-018386
Filing Date
2023-04-14
Accepted
2023-04-14 08:00:26
Documents
25

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007262x1_def14a.htm   iXBRL DEF 14A 1388017
6 hrmy_audit.jpg GRAPHIC 4450
7 hrmy_chair.jpg GRAPHIC 4948
8 hrmy_chairaudit.jpg GRAPHIC 5684
9 hrmy_member.jpg GRAPHIC 4597
10 logo_harmony.jpg GRAPHIC 51750
11 logo_harmonyx1.jpg GRAPHIC 40290
12 logo_harmonyx2.jpg GRAPHIC 18499
13 ny20007262x1_barchart01.jpg GRAPHIC 160539
14 ny20007262x1_barchart02.jpg GRAPHIC 91474
15 ny20007262x1_pc01.jpg GRAPHIC 704270
16 ny20007262x1_pc02.jpg GRAPHIC 553739
  Complete submission text file 0001140361-23-018386.txt   6546015

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hrmy-20230525.xsd EX-101.SCH 7351
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrmy-20230525_def.xml EX-101.DEF 10565
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrmy-20230525_lab.xml EX-101.LAB 35796
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrmy-20230525_pre.xml EX-101.PRE 33314
19 EXTRACTED XBRL INSTANCE DOCUMENT ny20007262x1_def14a_htm.xml XML 326351
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Filer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39450 | Film No.: 23819763
SIC: 2834 Pharmaceutical Preparations